Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
This trial will compare grade 2 or greater late skin toxicities of concomitant letrozole-radiotherapy and radiotherapy followed by letrozole as adjuvant therapy for postmenopausal women with receptor (estrogen receptor [ER] and/or progesterone receptor [PgR]) positive tumors. Each drug will be prescribed for 5 years.
Critère d'inclusion
- Breast Cancer